Concentra /
iTeos
Concentra to acquire iTeos Therapeutics




Source for the buyer and target: iTeos Therapeutics, Inc.
For the buyer and target.
“Based upon and subject to the foregoing, including the various assumptions and limitations set forth herein, it is our opinion that, as of the date hereof, the Upfront Cash Amount to be received by holders of iTeos Common Stock (other than, as applicable, Tang, Concentra, Merger Sub, and their respective affiliates) in the Transaction is fair, from a financial point of view, to such holders.”
Published 1 Aug 2025
Open the sourceWhat happened
Concentra agreed to acquire iTeos Therapeutics through a tender offer and merger. The transaction would provide iTeos stockholders with cash and contingent value rights. [01]
Terms of the definitive agreement were not stated in the provided text. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Concentra to acquire iTeos Therapeutics
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly